These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 27982082)
1. The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson's disease. Al-Hilaly YK; Biasetti L; Blakeman BJ; Pollack SJ; Zibaee S; Abdul-Sada A; Thorpe JR; Xue WF; Serpell LC Sci Rep; 2016 Dec; 6():39171. PubMed ID: 27982082 [TBL] [Abstract][Full Text] [Related]
2. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Conway KA; Harper JD; Lansbury PT Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204 [TBL] [Abstract][Full Text] [Related]
3. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease. Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933 [TBL] [Abstract][Full Text] [Related]
4. Opposed Effects of Dityrosine Formation in Soluble and Aggregated α-Synuclein on Fibril Growth. Wördehoff MM; Shaykhalishahi H; Groß L; Gremer L; Stoldt M; Buell AK; Willbold D; Hoyer W J Mol Biol; 2017 Oct; 429(20):3018-3030. PubMed ID: 28918091 [TBL] [Abstract][Full Text] [Related]
5. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Luk KC; Song C; O'Brien P; Stieber A; Branch JR; Brunden KR; Trojanowski JQ; Lee VM Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20051-6. PubMed ID: 19892735 [TBL] [Abstract][Full Text] [Related]
6. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies. Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153 [TBL] [Abstract][Full Text] [Related]
7. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains. Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884 [TBL] [Abstract][Full Text] [Related]
8. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain. Roberts RF; Wade-Martins R; Alegre-Abarrategui J Brain; 2015 Jun; 138(Pt 6):1642-57. PubMed ID: 25732184 [TBL] [Abstract][Full Text] [Related]
9. A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease. Al-Hilaly YK; Williams TL; Stewart-Parker M; Ford L; Skaria E; Cole M; Bucher WG; Morris KL; Sada AA; Thorpe JR; Serpell LC Acta Neuropathol Commun; 2013 Dec; 1():83. PubMed ID: 24351276 [TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease. Bhattacharjee P; Öhrfelt A; Lashley T; Blennow K; Brinkmalm A; Zetterberg H J Proteome Res; 2019 May; 18(5):2109-2120. PubMed ID: 30943367 [TBL] [Abstract][Full Text] [Related]
15. Observation of an α-synuclein liquid droplet state and its maturation into Lewy body-like assemblies. Hardenberg MC; Sinnige T; Casford S; Dada ST; Poudel C; Robinson EA; Fuxreiter M; Kaminksi CF; Kaminski Schierle GS; Nollen EAA; Dobson CM; Vendruscolo M J Mol Cell Biol; 2021 Aug; 13(4):282-294. PubMed ID: 33386842 [TBL] [Abstract][Full Text] [Related]
16. Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals. Borsarelli CD; Falomir-Lockhart LJ; Ostatná V; Fauerbach JA; Hsiao HH; Urlaub H; Paleček E; Jares-Erijman EA; Jovin TM Free Radic Biol Med; 2012 Aug; 53(4):1004-15. PubMed ID: 22771470 [TBL] [Abstract][Full Text] [Related]
17. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases. Yagi H; Kusaka E; Hongo K; Mizobata T; Kawata Y J Biol Chem; 2005 Nov; 280(46):38609-16. PubMed ID: 16162499 [TBL] [Abstract][Full Text] [Related]
18. Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element. Olivares D; Huang X; Branden L; Greig NH; Rogers JT Int J Mol Sci; 2009 Mar; 10(3):1226-60. PubMed ID: 19399246 [TBL] [Abstract][Full Text] [Related]
19. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo. Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202 [TBL] [Abstract][Full Text] [Related]
20. Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease. Danielson SR; Held JM; Schilling B; Oo M; Gibson BW; Andersen JK Anal Chem; 2009 Sep; 81(18):7823-8. PubMed ID: 19697948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]